ARCH, one of life sciences' premier investors, eyes $3B for 13th fund
ARCH Venture Partners plans to raise $3 billion for its 13th fund, per a new SEC filing from this week. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
